Clinical trials
Phase 3 trials in Nigeria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2004 | 2 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 7 |
| 2021 | 7 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Terminated | 8 |
| Recruiting | 7 |
| Active, not recruiting | 4 |
| Unknown status | 3 |
| Withdrawn | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 6 |
| GlaxoSmithKline | 5 |
| London School of Hygiene and Tropical Medicine | 4 |
| University of Birmingham | 3 |
| University of Lagos, Nigeria | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Novo Nordisk A/S | 2 |
| Population Health Research Institute | 2 |
| University of Minnesota | 2 |
| Vanderbilt University Medical Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Sickle Cell | 12 |
| COVID-19 | 6 |
| Stroke | 6 |
| Malaria, Falciparum | 5 |
| Breast Neoplasms | 4 |
| Hematologic Diseases | 4 |
| Malaria | 4 |
| Severe Acute Respiratory Syndrome | 4 |
| Vaso-Occlusive Crises | 4 |
| Anemia | 3 |
Trials
Showing 51 to 51 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.